Comparative analysis of azithromycin and ciprofloxacin in the treatment of chronic prostatitis caused by Chlamydia trachomatis

International Journal of Antimicrobial Agents

Volumn 21, Issue 5, 2003, Pages 457-462

  Škerk, Višnja ^a   Schönwald, Slavko ^a   Krhen, Ivan ^b   Banaszak, Arthur ^c   Begovac, Josip ^a   Strugar, Jadranka ^c   Strapac, Zvonimir ^c   Vrsalovic, Renata ^a   Vukovic, Jacinta ^c   Tomas, Margita ^c  

^a Croatia   (Croatia)

^b KBC Zagreb   (Croatia)

^c PLIVA CROATIA LTD   (Croatia)

Author keywords

Azithromycin; Chlamydia trachomatis; Ciprofloxacin; Prostatitis; Treatment

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DNA; DOXYCYCLINE; ERYTHROMYCIN; LUGOL; OFLOXACIN; RIFAMPICIN; RNA; SULFAMETHOXAZOLE; TETRACYCLINE;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BLADDER; CHLAMYDIA TRACHOMATIS; CHRONIC PROSTATITIS; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA ISOLATION; DRUG EFFICACY; DRUG SCREENING; DRUG SENSITIVITY; ERADICATION THERAPY; FEMALE; HUMAN; INFLAMMATION; LIVER DYSFUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MICTURITION; NAUSEA; PATIENT; PRIORITY JOURNAL; PROSTATE SECRETION; RANDOMIZED CONTROLLED TRIAL; SEXUALITY; TREATMENT OUTCOME; URINALYSIS;

EID: 0242501548     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(03)00056-6     Document Type: Article

References (36)

1. European Association of Urology. Guidelines on urinary and male genital tract infections. Drukkerij Gelderland bv, Arnhem, the Netherlands, 2002; 49-56.
2. Meares E.M., Stamey T.A. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest. Urol. 5:1968;492-518.
3. Drach G.W., Meares E.M., Fair W.R., Stamey T.A. Classification of benign diseases associated with prostatic pain: Prostatitis or prostatodynia? J. Urol. 120:1978;266.
4. Workshop Committee of the National Institute of Diabetes and Digestive and Kidney Diseases (NICCK). Chronic Prostatitis Workshop, Bethesda, MD, 7-8 December, 1995.
5. Škerk V., Schönwald S., Krhen I., et al. Etiology of chronic prostatitis. Int. J. Antim. Agents. 19:2002;471-474.
6. Hoosen A.A., O'Farrell N., van den Ende J. Microbiology of acute epididymitis in a developing community. Genitourin. Med. 69:1993;361-363.
7. Weidner W., Diemer Th., Huwe P., Rainer M., Ludwig M. The role of Chlamydia trachomatis in prostatitis. Int. J. Antim. Agents. 19:2002;466-470.
8. Nilsson S., Johannisson G., Lycke E. Isolation of C. trachomatis from the urethra and from prostatic fluid in men with signs and symptoms of acute urethritis. Acta Derm. Venerol. 61:1981;456-458.
9. Brunner H., Weidner W. Acute and chronic prostatitis. Taylor-Robinson D. Clinical problems in sexually transmitted diseases. 1985;37-59 Martinus Nijhoff Publishers, Dordrecht.
10. Johannisson G. Studies on C. trachomatis as a cause of lower urogenital tract infection. Acta. Derm. Venerol. 93:(Suppl.):1981;1.
11. Weidner W., Schiefer H.G. Isolation of C. trachomatis from the prostatic cells in patients affected by non-acute abacterial prostatitis. J. Urol. 134:1985;690. (letter to the Editor).
12. Weidner W., Arens M., Kraus H., Schiefer H.G., Ebner H. Chlamydia trachomatis in abacterial prostatitis: microbiological, cytological and serological studies. Urol. Int. 38:1984;146-149.
13. Bruce A.W., Reid G. Prostatitis associated with Chlamydia trachomatis in 6 patients. J. Urol. 142:1989;1006-1007.
14. Gümüs B., Sengil A.Z., Solak M., et al. Evaluation of non-invasive clinical samples in chronic chlamydial prostatitis by using in situ hybridization. Scand. J. Urol. Nephrol. 31:1997;449-451.
15. Heqing G., Gongenheng L., Qijun Z., Xulin X. Detection of Chlamydia trachomatis by polymerase chain reaction assay in nonbacterial prostatitis. Chin. Med. J. 110:1997;177-179.
16. Kadar A., Bucsek K., Kardos M., Corradi G. Detection of Chlamydia trachomatis in chronic prostatitis by in situ hybridization (preliminary methodical report). Orvosi. Hetilap. 136:1995;659-662.
17. Koroku M., Kumamoto Y., Hirose T. A study on the role of Chlamydia trachomatis in chronic prostatitis - analysis of anti-Chlamydia trachomatis specific IgA in expressed prostate secretion by Western-blotting method. J. Jpn. Assoc. Infect. Dis. 69:1995;426-437.
18. Yu P., Hu F., Shi X., Wang F., Shu M., Mao X. Laboratory diagnosis of Chlamydia trachomatis and Ureaplasma urealyticum of chronic prostatitis. Bull. Hum. Med. Univ. 23:1998;537-539.
19. Mutlu N., Mutlu B., Culha M., Hamsioglu Z., Demirtas M., Gokalp A. The role of Chlamydia trachomatis in patients with non-bacterial prostatitis. Int. J. Clin. Pract. 52:1998;540-541.
20. Schacter J. Infection and disease immunology. Stephens R.S. Chlamydia: intracellular biology, pathogenesis, and immunity. 1999;139-170 ASM Press, Washington DC.
21. Weider W., Schiefer H.G., Krauss H., Jantos Ch., Friedrich H.J., Altmannsberger M. Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1461 patients. Infection. 19:(Suppl. 3):1991;119-125.
22. Schaeffer A.J. Diagnosis and management of prostatitis. Braz. J. Urol. 26:2000;122-131.
23. Schachter J., Stamm W.E. Chlamydia. Murray P.R., Baron E.J., Phaller M.A., Tenover F.C., Yolken R.H. Manual of clinical microbiology. 7th ed. 1999;795-806 ASM Press, Washington DC.
24. Jones R.B., Batteiger B.E. Chlamydia trachomatis (trachoma, perinatal infections, lymphogranuloma venereum and other genital infections). Mandell G.L., Bennett J.E., Dolin R. Principles and practice of infectious diseases. 2000;1989-2004 Churchill Livingstone, Philadelphia, PA.
25. Quinn T.C., Gaydos C., Shepherd M., et al. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. J. Am. Med. Assoc. 276:1996;1737-1742.
26. Naber K.G., Weidner W. Prostatitis, epididymitis and orchitis. Armstrong D., Cohen J. Infectious diseases. 1999;2.58.1-2.58.6 Mosby, London.
27. Jones R.B., Van der Pol B., Martin D.H., Shepard M.K. Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics. J. Infect. Dis. 162:1990;1309-1315.
28. Steigbigel N.H. Macrolides and clindamycin. Mandell G.L., Bennett J.E., Dolin R. Principles and practice of infectious diseases. 2000;366-382 Churchill Livingstone, Philadelphia, PA.
29. Black C.H., Byrne G., Carlin E., et al. Chlamydia trachomatis genital infections and single dose azithromycin therapy. Rev. Contemp. Pharmacother. 11:2000;139-256.
30. Škerk V., Schönwald S., Krhen I., et al. Azithromycin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. J. Chemother. 13:2001;664-665.
31. Hopper D.C. Quinolones. Mandell G.L., Bennett J.E., Dolin R. Principles and practice of infectious diseases. 2000;404-423 Churchill Livingstone, Philadelphia, PA.
32. Waldron R., Arkell D.G., Wise R., Andrews J.M. The intraprostatic penetration of ciprofloxacin. J. Antimicrob. Chemother. 17:1986;544-545.
33. Arya O.P., Hobson D., Hart C.A., Bartzokas C., Pratt B.C. Evaluation of ciprofloxacin 500 mg twice daily for one week in treating uncomplicated gonococcal, chlamydial and non-specific urethritis in men. Genitourin. Med. 62:1986;170-174.
34. Stolz E., Wagenvoort J.H.T., Van der Willigen A.H. Quinolones in the treatment of gonorrhoea and Chlamydia trachomatis infection. Pharm. Weekbl. (Sci.). 9:(Suppl.):1987;82-85.
35. Perea E.J., Aznar J., Herrera A., Mazuecos J., Rodriguez-Pichardo A. Clinical efficacy of new quinolones for therapy of nongonococcal urethritis. Sex. Transm. Dis. 16:1989;7-10.
36. Heinonen P.K., Teisala K., Miettinen A., Aine R., Punnonen R., Grönroos P. A comparison of ciprofloxacin with doxycycline plus metronidazole in the treatment of acute pelvic inflammatory disease. Scand. J. infect. Dis. 60:(Suppl.):1989;66-73.